Drugs Made In America Acquisition Corp. Ordinary Shares
DMAANASDAQ
Financial Services
$10.49
-0.01(-0.10%)
Mkt Cap $352M
$10.02
$10.52
52-Week Range
At a Glance
AI-generated8-K
Drugs Made In America Acquisition Corp. entered into a Definitive Interim Investment and Sponsor Transition Agreement with BV Advisory Partners, LLC on March 23, 2026, issuing a $100,000 interim convertible note as the first tranche of a contemplated $500,000 financing. The proceeds are intended for expenses related to a potential business combination, and the investor has introduced a specific target opportunity involving an enterprise technology platform.$352M
Market Cap
—
Revenue
$8M
Net Income
Employees2
Fundamentals
How The Business Makes Money
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Industry Shell Companies
Activity
What Changed Recently
Company Profile
CIK0002028614
ISINKYG2847J1040
Address1 East Broward Blvd Suite 700, Fort Lauderdale, FL, 33301, US
SEC EDGAR